Cargando…

The MAOA rs979605 Genetic Polymorphism Is Differentially Associated with Clinical Improvement Following Antidepressant Treatment between Male and Female Depressed Patients

Major depressive disorder (MDD) is the leading cause of disability worldwide. Treatment with antidepressant drugs (ATD), which target monoamine neurotransmitters including serotonin (5HT), are only modestly effective. Monoamine oxidase (MAO) metabolizes 5HT to 5-hydroxy indoleacetic acid (5HIAA). Ge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chappell, Kenneth, Colle, Romain, Bouligand, Jérôme, Trabado, Séverine, Fève, Bruno, Becquemont, Laurent, Corruble, Emmanuelle, Verstuyft, Céline
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820795/ https://www.ncbi.nlm.nih.gov/pubmed/36613935 http://dx.doi.org/10.3390/ijms24010497

Ejemplares similares

The association of ARRB1 polymorphisms with response to antidepressant treatment in depressed patients
por: Chappell, Kenneth, et al.
Publicado: (2022)

Human Dermal Fibroblast: A Promising Cellular Model to Study Biological Mechanisms of Major Depression and Antidepressant Drug Response
por: Mesdom, Pierre, et al.
Publicado: (2020)

Blood microbiota and metabolomic signature of major depression before and after antidepressant treatment: a prospective case–control study
por: Ciocan, Dragos, et al.
Publicado: (2021)

The TRKB rs2289656 genetic polymorphism is associated with acute suicide attempts in depressed patients: A transversal case control study
por: Deflesselle, Eric, et al.
Publicado: (2018)

Non-overweight depressed patients who respond to antidepressant treatment have a higher risk of later metabolic syndrome: findings from the METADAP cohort
por: El Asmar, K., et al.
Publicado: (2023)

Liver Function Test Abnormalities in Depressed Patients Treated with Antidepressants: A Real-World Systematic Observational Study in Psychiatric Settings
por: Voican, Cosmin Sebastian, et al.
Publicado: (2016)

The human plasma-metabolome: Reference values in 800 French healthy volunteers; impact of cholesterol, gender and age
por: Trabado, Séverine, et al.
Publicado: (2017)

Major Depressive Disorder and Oxidative Stress: A Review of Peripheral and Genetic Biomarkers According to Clinical Characteristics and Disease Stages
por: Ait Tayeb, Abd El Kader, et al.
Publicado: (2023)

Hydroxychloroquine, Interleukin-6 Receptor Antagonists and Corticoid Treatments of Acute COVID-19 Infection: Psychiatric Symptoms and Mental Disorders 4 Months Later
por: Gasnier, Matthieu, et al.
Publicado: (2022)

Pioglitazone could induce remission in major depression: a meta-analysis
por: Colle, Romain, et al.
Publicado: (2016)

128. Long Covid and Psychiatric Disorders 4 Months After a Hospitalization for COVID-19: A Cross Sectional Study
por: Gasnier, Matthieu, et al.
Publicado: (2023)

Astroglial Connexins Inactivation Increases Relapse of Depressive-like Phenotype after Antidepressant Withdrawal
por: Portal, Benjamin, et al.
Publicado: (2022)

Intra-nasal Esketamine Induced Psychotic Disorder in a Post Covid-19 Major Depressive Episode: a case report
por: Tang, Julie, et al.
Publicado: (2023)

Anosmia during acute COVID-19 and psychiatric outcomes 4 months later: Results from the prospective COMEBAC cohort
por: Faulet, Théo, et al.
Publicado: (2023)

Peripheral tryptophan and serotonin and kynurenine pathways in major depression: A case-control study
por: Colle, R., et al.
Publicado: (2021)

Hippocampal volume predicts antidepressant efficacy in depressed patients without incomplete hippocampal inversion
por: Colle, Romain, et al.
Publicado: (2016)

Familial Glucocorticoid Receptor Haploinsufficiency by Non-Sense Mediated mRNA Decay, Adrenal Hyperplasia and Apparent Mineralocorticoid Excess
por: Bouligand, Jérôme, et al.
Publicado: (2010)

Use of potentially driver-impairing drugs among older drivers
por: Zitoun, Sarah, et al.
Publicado: (2022)

Association between car driving and successful ageing. A cross sectional study on the "S.AGES" cohort
por: Baudouin, Edouard, et al.
Publicado: (2023)

Psychiatric disorders and long COVID
por: Gasnier, Matthieu, et al.
Publicado: (2022)

P124. Which Patients Will Have Mental Disorders After Hospitalization for COVID-19?
por: Gasnier, Matthieu, et al.
Publicado: (2022)

Early life adversity is associated with a smaller hippocampus in male but not female depressed in-patients: a case–control study
por: Colle, Romain, et al.
Publicado: (2017)

Psychological distress among outpatient physicians in private practice linked to COVID-19 and related mental health during the second lockdown
por: Frajerman, Ariel, et al.
Publicado: (2022)

Telemedicine use during the COVID-19 lockdown is associated with fewer depressive symptoms among physicians in private practice
por: Frajerman, Ariel, et al.
Publicado: (2023)

Functional Characterization of Glucocorticoid Receptor Variants Is Required to Avoid Misinterpretation of NGS Data
por: Foussier, Loïc, et al.
Publicado: (2019)

MAOA rs1137070 and heroin addiction interactively alter gray matter volume of the salience network
por: Sun, Yan, et al.
Publicado: (2017)

Pharmacological Mechanism of Ketamine in Suicidal Behavior Based on Animal Models of Aggressiveness and Impulsivity: A Narrative Review
por: Nguyen, Thi Mai Loan, et al.
Publicado: (2023)

Santé mentale des médecins libéraux français pendant la deuxième vague de COVID 19
por: Frajerman, Ariel, et al.
Publicado: (2023)

MAOA Influences the Trajectory of Attentional Development
por: Lundwall, Rebecca A., et al.
Publicado: (2016)

MAOA haplotypes associated with thrombocyte-MAO activity
por: Jansson, Mårten, et al.
Publicado: (2005)

MAOA EXPRESSION PREDICTS VULNERABILITY FOR ALCOHOL USE
por: Cervera-Juanes, Rita, et al.
Publicado: (2015)

Plasticity of Functional MAOA Gene Methylation in Acrophobia
por: Schiele, Miriam A, et al.
Publicado: (2018)

Retraction “Methylation of the MAOA promoter is associated with schizophrenia”
por: Yang, Hao, et al.
Publicado: (2020)

The ability of early changes in motivation to predict later antidepressant treatment response
por: Gorwood, Philip, et al.
Publicado: (2015)

The criminal gene: the link between MAOA and aggression (REVIEW)
por: Sohrabi, S
Publicado: (2015)

Differential Peripheral Proteomic Biosignature of Fluoxetine Response in a Mouse Model of Anxiety/Depression
por: Mendez-David, Indira, et al.
Publicado: (2017)

Association of Monoamine Oxidase A (MAOA) Gene uVNTR and rs6323 Polymorphisms with Attention Deficit and Hyperactivity Disorder in Korean Children
por: Hwang, In Wook, et al.
Publicado: (2018)

Normosmic Congenital Hypogonadotropic Hypogonadism Due to TAC3/TACR3 Mutations: Characterization of Neuroendocrine Phenotypes and Novel Mutations
por: Francou, Bruno, et al.
Publicado: (2011)

Ketamine and esketamine in suicidal thoughts and behaviors: a systematic review
por: Jollant, Fabrice, et al.
Publicado: (2023)

The MAOA Gene Influences the Neural Response to Psychosocial Stress in the Human Brain
por: Sun, Xiaoqiang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8f1vntvquj4etcm22vo0tmhhgf